Pentasa

Ulcerative Colitis Treatment

Pentasa is primarily used to treat and manage ulcerative colitis, a type of inflammatory bowel disease (IBD) that causes swelling and sores in the lining of the colon and rectum. It is specifically indicated for patients with mildly to moderately active symptoms.

Inducing and Maintaining Remission

This medication is used for both short-term relief and long-term management:

• Active Flare-ups: Pentasa helps reduce inflammation during active periods of the disease to help bring symptoms like rectal bleeding and stomach pain under control.
• Prevention: It is also used as a maintenance therapy to help keep the disease in remission and prevent symptoms from coming back.

By reducing inflammation directly in the digestive tract, Pentasa helps the intestinal lining heal and improves the patient's quality of life by reducing the frequency of bowel movements and discomfort.

Mechanism of Action

Pentasa contains mesalamine, a medication in the aminosalicylate class. It is used to treat and maintain remission in patients with ulcerative colitis. While the exact way the drug works is not fully understood, it is believed to have a local effect on the tissues of the digestive tract.

Unlike many medications that must be absorbed into the bloodstream to be effective, mesalamine is thought to work topically on the inner lining of the colon and rectum. It helps manage the condition through several processes:

• Reducing Inflammatory Chemicals: The medication may block the production of certain substances in the body, such as prostaglandins and leukotrienes, which are known to cause swelling and irritation in the bowel.
• Local Anti-inflammatory Effect: By acting directly on the site of inflammation, it helps soothe the intestinal lining.
• Tissue Protection: It may also help decrease the activity of certain enzymes and molecules that contribute to tissue damage during an inflammatory flare-up.

By controlling inflammation, Pentasa helps reduce common symptoms of ulcerative colitis, such as diarrhea, rectal bleeding, and stomach pain, while allowing the intestinal lining time to heal.

Common Side Effects

Many people using this medication do not have serious side effects. Common symptoms may include:

• Nausea, vomiting, or stomach pain
• Diarrhea or gas
• Headache or dizziness
• Back pain
• Fever, sore throat, or other flu-like symptoms
• Rash or itching

Serious Side Effects

Seek medical attention immediately if you experience any of the following serious symptoms:

• Acute intolerance syndrome: This may include severe stomach pain, cramping, bloody diarrhea, fever, headache, and rash. These symptoms may be similar to the symptoms of the condition being treated.
• Kidney problems: Signs include swelling in the face, hands, or feet; rapid weight gain; or changes in the frequency or color of urination.
• Liver problems: Symptoms include loss of appetite, upper stomach pain, unusual tiredness, dark urine, or yellowing of the skin or eyes.
• Heart issues: Chest pain, pounding heartbeats, or shortness of breath.
• Severe skin reactions: Fever, sore throat, burning eyes, skin pain, or a red or purple skin rash that spreads and causes blistering and peeling.

Renal Impairment

Kidney damage, including minimal change disease and chronic inflammation of the kidneys, has been reported with mesalamine use. It is recommended that kidney function be evaluated before starting treatment and periodically during therapy. Caution is used when administering this medication to individuals with known kidney disease or those taking other medications that can affect the kidneys.

Mesalamine-Induced Acute Intolerance Syndrome

Mesalamine has been associated with an acute intolerance syndrome that may be difficult to distinguish from a flare-up of inflammatory bowel disease. Symptoms can include abdominal pain, cramping, bloody diarrhea, fever, headache, and rash. If these symptoms occur, the medication should be discontinued immediately.

Hypersensitivity Reactions

Serious hypersensitivity reactions have occurred, including inflammation of the heart muscle (myocarditis) and the sac surrounding the heart (pericarditis). Other rare but serious reactions include lung inflammation (interstitial pneumonitis) and severe skin reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis.

Photosensitivity

Individuals with pre-existing skin conditions, such as atopic dermatitis or eczema, may experience increased sensitivity to sunlight. It is advised to limit sun exposure and use protective clothing or sunscreen while taking this medication.

Hepatic Failure

There have been reports of liver failure in patients with pre-existing liver disease who take mesalamine. Caution is advised for those with impaired liver function, and the risks should be weighed against the benefits of treatment.

Kidney Stones

The use of mesalamine has been linked to the formation of kidney stones (nephrolithiasis). Maintaining adequate fluid intake during treatment may help reduce the risk of stone formation.

Interactions with Other Medications

Using mesalamine alongside certain medications, such as azathioprine or 6-mercaptopurine, may increase the risk of blood disorders, including a significant drop in white blood cell counts. Regular monitoring of blood cell counts is typically recommended if these drugs are used together.

Pregnancy

Limited data are available on the use of mesalamine in pregnant women. While animal studies have not demonstrated a risk of fetal harm, mesalamine is known to cross the placental barrier. It should be used during pregnancy only if the potential benefits justify the potential risks to the fetus.

Breastfeeding

Mesalamine and its primary metabolite are excreted in human breast milk. There have been reports of diarrhea in infants who are breastfed while the mother is taking this medication. Caution is recommended if Pentasa is administered to a nursing woman. Healthcare providers typically advise monitoring the infant for any changes in bowel habits.

Medical Consultation

If you are pregnant, planning to become pregnant, or breastfeeding, it is important to discuss your treatment plan with your doctor. They can provide guidance based on your specific health needs and the potential risks involved.

Available Forms

Pentasa is supplied in the following oral dosage form:

• Extended-release capsules: These capsules are designed to release the active ingredient in a controlled manner as they pass through the small intestine and the colon.

FDA Approval and Indications

Pentasa (mesalamine) is approved by the U.S. Food and Drug Administration (FDA) as a controlled-release oral capsule. It is specifically indicated for the induction of remission and for the treatment of adults with mildly to moderately active ulcerative colitis.

Regulatory Classification

Pentasa is a prescription-only medication and is not classified as a controlled substance. It belongs to the aminosalicylate class of drugs, which are used to reduce inflammation in the lining of the colon.

Safety Monitoring and Warnings

The FDA has not issued a Boxed Warning for Pentasa, nor is there a Risk Evaluation and Mitigation Strategy (REMS) required for its distribution. However, the FDA-approved labeling includes specific safety precautions. Healthcare providers are advised to evaluate renal function in all patients prior to starting therapy and periodically during treatment, as mesalamine has been associated with kidney impairment. Additionally, the FDA monitors reports of rare but serious adverse effects, such as mesalamine-induced acute intolerance syndrome and severe skin reactions.

Generic Availability

Generic versions of Pentasa (mesalamine extended-release capsules) are available. Generic medications are typically more affordable than brand-name drugs and are required to meet the same standards for safety, strength, and quality.

Factors Influencing Cost

Several factors can affect the final price of your prescription:

• Insurance Coverage: Your out-of-pocket costs are determined by your insurance plan's formulary, deductible, and copayment levels. Some plans may require prior authorization.
• Pharmacy Choice: Prices may differ between retail pharmacies, mail-order services, and specialty pharmacies.
• Dosage and Quantity: The total cost will depend on the strength of the capsules and the number of capsules prescribed for your treatment.

Financial Assistance Programs

If you have difficulty paying for Pentasa, there may be options to help reduce the cost:

• Manufacturer Savings: The manufacturer may offer savings cards or coupons for eligible patients with commercial insurance.
• Patient Assistance Programs: Some programs provide medications at a lower cost or for free to individuals who meet specific income requirements and lack adequate insurance coverage.

It is recommended to speak with your pharmacist or healthcare provider to explore the most cost-effective options for your treatment.